Our study aimed to assess the knowledge of PHCC physicians in Qassim regarding novel classes of type 2 diabetes medications, including GLP-1 RA, DPP-4i, and SGLT-2i. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.